Rosalind Advisors’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,480
Closed -$50.8K 32
2024
Q2
$50.8K Buy
+2,480
New +$50.8K 0.04% 34